ContraFect Competitors

Delisted . USA . 
Stock . ContraFect Corp
CFRXDelisted Stock  USD 1.18  0.08  6.35%   
ContraFect Corp competes with Palisade Bio, Allarity Therapeutics, Cns Pharmaceuticals, Windtree Therapeutics, and Quoin Pharmaceuticals; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing ContraFect Corp competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of ContraFect Corp to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of ContraFect Corp competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
1.181.181.18
Details
Intrinsic
Valuation
LowRealHigh
1.121.121.30
Details
Naive
Forecast
LowNextHigh
1.301.301.30
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.131.211.28
Details

ContraFect Corp Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between ContraFect Corp and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of ContraFect and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of ContraFect Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
VRAX
+ 0.93
ALLR
VRAX
+ 0.89
WINT
WINT
+ 0.85
ALLR
VRAX
+ 0.84
REVB
REVB
+ 0.82
WINT
NRBO
+ 0.81
ALLR
  
High negative correlations   
UNCY
- 0.71
PALI
UNCY
- 0.63
ALLR
NRBO
- 0.57
UNCY
UNCY
- 0.48
WINT
UNCY
- 0.47
VRAX
UNCY
- 0.47
CNSP

Risk-Adjusted Indicators

There is a big difference between ContraFect Stock performing well and ContraFect Corp Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ContraFect Corp's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

ContraFect Corp Competitive Analysis

The better you understand ContraFect Corp competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, ContraFect Corp's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across ContraFect Corp's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
CFRX PALI ALLR CNSP WINT QNRX REVB VRAX UNCY NRBO
 6.35 
 1.18 
ContraFect
 0.41 
 2.44 
Palisade
 0.79 
 1.27 
Allarity
 7.69 
 0.12 
Cns
 1.96 
 0.50 
Windtree
 4.84 
 0.59 
Quoin
 1.33 
 0.76 
Revelation
 3.61 
 2.01 
Virax
 3.92 
 0.53 
Unicycive
 0.85 
 2.37 
Neurobo
Market Volatility
(90 Days Market Risk)
Very steady
Relatively risky
Dangerous
Dangerous
Abnormally volatile
Slightly risky
Very risky
Risky
Extremely Dangerous
Risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Very Weak
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Very High
Very High
Very High
Very High
Average
Very High
Low
Low
Low
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Hold
Buy
Hold
Buy
Buy
Strong Sell
Strong Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Current Ratio
1.83
2.59
0.88
12.34
2.47
0.96
0.68
0.04
4.43
8.07
Net Asset
20.68 M
14.05 M
11.86 M
1.7 M
32.41 M
12.17 M
12.21 M
5.48 M
14.19 M
22.78 M
EBITDA
(30.05 M)
(12.28 M)
(12.08 M)
(18.86 M)
(20.16 M)
(9.27 M)
(95.21 K)
(6.61 M)
(30.18 M)
(15.88 M)
Current Valuation
(2.32 M)
(3.95 M)
(11.5 M)
531.33 K
5.97 M
(7.35 M)
9.46 M
5.36 M
23.47 M
(1.27 M)
Price To Book
0.44
0.56
0.43
2.23
1.26
0.54
1.21
1.63
1.98
1.56
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
-42.54
N/A
N/A
Retained Earnings
(325.7 M)
(121.51 M)
(94.45 M)
(69.57 M)
(844.82 M)
(46.2 M)
(25.47 M)
(18.53 M)
(64.54 M)
(108.27 M)
Current Asset
34.1 M
N/A
N/A
6.61 M
40.79 M
N/A
N/A
N/A
N/A
21.62 M
Beta
0.29
1.33
0.29
1.05
0.64
1.89
0.15
1.93
2.29
-0.28
Number Of Employees
23
9
5
3
N/A
4
9
17
14
8
Shares Outstanding
10.7 M
1.33 M
1.41 M
40.75 M
8.75 M
5.05 M
4.29 M
4.34 M
103.8 M
8.62 M
Cash Flow From Operations
(35.59 M)
(11.13 M)
(12.74 M)
(14.14 M)
(13.44 M)
(7.86 M)
(7.29 M)
(6.25 M)
(18.28 M)
(10.8 M)
Total Debt
2.88 M
369 K
1.3 M
300.81 K
16.83 M
3.52 K
5.56 M
224.3 K
811 K
203 K
Return On Equity
-6.09
-1.1
-1.22
-10.19
-1.51
-1.0
-2.7
-0.96
-1.22
-1.61
Z Score
-26.92
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-1.17
-0.59
-0.48
-2.24
-0.45
-0.36
-0.51
-0.5
-0.53
-0.74
Number Of Shares Shorted
115.97 K
43.11 K
179.44 K
1.14 M
195.67 K
478.43 K
41.24 K
446.54 K
1.05 M
19.2 K
Book Value Per Share
-0.54
18.3
16.98
-2.97
5.9
5.74
0.62
2.09
-0.11
1.51
Current Liabilities
3.77 M
N/A
N/A
488.66 K
11.07 M
N/A
N/A
N/A
N/A
11.75 M
Total Asset
20.68 M
14.05 M
11.86 M
1.7 M
32.41 M
12.17 M
12.21 M
5.48 M
14.19 M
22.78 M
Debt To Equity
0.24
0.23
0.11
0.013
0.95
0.47
0.009
N/A
0.023
0.005
Short Ratio
1.18
0.29
0.3
0.04
0.06
0.2
0.69
0.11
0.74
0.38
Target Price
7.0
30.33
5.0
0.5
7.0
4.5
12.75
20.0
5.5
26.67
Shares Owned By Institutions
6.13
3.57
1.2
0.7
0.59
5.88
2.31
5.37
38.2
12.71
Market Capitalization
535.24 K
3.73 M
2.06 M
5.28 M
4.92 M
2.95 M
3.24 M
8.73 M
55.01 M
20.42 M
Price To Earning
21.36
0.16
N/A
-13.7
-0.05
N/A
8.69
N/A
N/A
-1.44
Price To Sales
N/A
14.03
N/A
N/A
660.53
N/A
2.88
55.79
62.82
N/A
Net Income
(24.14 M)
(12.3 M)
(11.9 M)
(18.85 M)
(20.29 M)
(8.69 M)
(120.25 K)
(6.74 M)
(30.54 M)
(12.47 M)
Earnings Per Share
-10.83
-13.26
-10.98
-352.97
-19.03
-3.66
-17.53
-3.36
-0.46
-4.29
Shares Owned By Insiders
0.65
1.88
12.3
1.2
0.27
2.44
0.12
7.06
6.73
65.23
Revenue
N/A
250 K
N/A
N/A
N/A
N/A
N/A
156.42 K
675 K
7 K
Working Capital
(3.13 M)
10.74 M
(12.2 M)
(4.54 M)
1.38 M
7.7 M
6.58 M
4.21 M
(4.13 M)
16.55 M
Cash And Equivalents
27.3 M
5 M
7.73 M
8.96 M
11.38 M
2.69 M
3.48 M
21.76 K
10.57 M
8.85 M
Cash Per Share
0.69
0.23
0.75
0.22
0.37
0.56
0.15
N/A
0.7
9.96
Gross Profit
(1.61 M)
N/A
(36.35 M)
N/A
(17.79 M)
N/A
90.91 M
(1.36 K)
N/A
N/A
Day Typical Price
1.21
2.5
1.26
0.12
0.5
0.6
0.75
2.01
0.52
2.39
Accumulation Distribution
0.11
0.13
0.0391
0.15
0.0392
0.0328
0.0395
0.0905
0.0741
0.0408
Market Facilitation Index
0.14
0.35
0.05
0.02
0.02
0.02
0.03
0.19
0.04
0.1
Daily Balance Of Power
(0.57)
0.0286
0.2
(0.50)
(0.50)
(1.50)
0.3333
0.3684
0.5
0.2
Period Momentum Indicator
(0.08)
0.01
0.01
(0.01)
(0.01)
(0.03)
0.01
0.07
0.02
0.02
Rate Of Daily Change
0.94
1.0
1.01
0.92
0.98
0.95
1.01
1.04
1.04
1.01
Day Median Price
1.22
2.53
1.25
0.12
0.5
0.6
0.75
2.01
0.52
2.4
Price Action Indicator
(0.08)
(0.08)
0.02
(0.01)
(0.01)
(0.03)
0.02
0.04
0.02
(0.02)
Relative Strength Index
7.95
36.5
36.56
35.05
43.29
59.54
24.93
58.89
50.52
27.61
Coefficient Of Variation
(3,478)
(1,056)
(400.13)
(2,789)
(334.16)
2407.25
(963.18)
(895.86)
830.61
(896.86)
Mean Deviation
5.26
3.52
5.02
4.99
7.19
6.2
3.66
5.89
4.0
3.39
Jensen Alpha
(0.40)
(0.50)
(1.99)
(0.47)
(4.13)
0.2535
(0.84)
(1.00)
0.5532
(0.84)
Total Risk Alpha
(1.69)
(1.24)
(3.03)
(1.44)
(5.60)
(1.25)
(1.51)
(2.52)
(0.21)
(1.31)
Sortino Ratio
N/A
N/A
N/A
N/A
N/A
0.0424
N/A
N/A
0.0884
N/A
Downside Variance
N/A
N/A
N/A
N/A
N/A
54.86
N/A
N/A
33.52
N/A
Standard Deviation
9.01
4.88
7.42
7.38
12.24
10.71
5.75
9.32
5.34
4.85
Kurtosis
13.92
3.24
2.46
1.58
9.69
13.24
7.74
13.19
1.46
3.92
Potential Upside
12.23
5.97
10.85
9.09
9.58
17.65
8.97
9.65
9.76
6.76
Treynor Ratio
(0.25)
(1.92)
(1.81)
(0.17)
(0.98)
0.2894
(0.31)
2.77
0.9626
(0.23)
Maximum Drawdown
55.69
24.25
41.48
39.29
62.78
74.46
34.52
61.28
29.22
25.62
Variance
81.14
23.85
55.09
54.52
149.92
114.8
33.01
86.79
28.49
23.49
Market Risk Adjusted Performance
(0.24)
(1.91)
(1.80)
(0.16)
(0.97)
0.2994
(0.30)
2.78
0.9726
(0.22)
Risk Adjusted Performance
(0.01)
(0.06)
(0.18)
(0.02)
(0.22)
0.0411
(0.07)
(0.08)
0.1009
(0.08)
Skewness
3.17
0.5171
(0.46)
0.781
(0.69)
2.6
1.82
2.57
0.5903
1.44
Semi Deviation
N/A
N/A
N/A
N/A
N/A
6.71
N/A
N/A
4.24
N/A
Information Ratio
(0.04)
(0.12)
(0.27)
(0.05)
(0.31)
0.0293
(0.13)
(0.13)
0.0959
(0.14)
Value At Risk
(8.45)
(8.55)
(16.11)
(11.76)
(18.48)
(9.68)
(7.83)
(12.97)
(7.41)
(7.34)
Expected Short fall
N/A
N/A
N/A
N/A
N/A
(8.97)
N/A
N/A
(5.20)
N/A
Downside Deviation
N/A
N/A
N/A
N/A
N/A
7.41
N/A
N/A
5.79
N/A
Semi Variance
N/A
N/A
N/A
N/A
N/A
45.03
N/A
N/A
17.96
N/A

ContraFect Corp Competition Performance Charts

Five steps to successful analysis of ContraFect Corp Competition

ContraFect Corp's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by ContraFect Corp in relation to its competition. ContraFect Corp's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of ContraFect Corp in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact ContraFect Corp's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to ContraFect Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your ContraFect Corp position

In addition to having ContraFect Corp in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Utilities Thematic Idea Now

Utilities
Utilities Theme
Highly leveraged corporations that deliver utilities such as power, water or gas to public or business. The Utilities theme has 30 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in ContraFect Stock

If you are still planning to invest in ContraFect Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ContraFect Corp's history and understand the potential risks before investing.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY